BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 2195624)

  • 1. [Verapamil and hypertension--(multicenter study of the efficacy and tolerance of delayed-action verapamil in the treatment of essential hypertension)].
    Kreuter U; Mühlemann M; Vogt E; Wohlwend MC
    Rev Med Suisse Romande; 1990 Jun; 110(6):551-8. PubMed ID: 2195624
    [No Abstract]   [Full Text] [Related]  

  • 2. [Treatment of hypertension with a delayed-action form of verapamil and its effect on hypertrophy and function of the left ventricle].
    Spacek R; Kozák P; Stárek A; Hes I; Skalníková V
    Vnitr Lek; 1987 Nov; 33(11):953-61. PubMed ID: 2964119
    [No Abstract]   [Full Text] [Related]  

  • 3. Verapamil SR and propranolol LA: a comparison of efficacy and side effects in the treatment of mild to moderate hypertension.
    Bochsler JA; Simmons RL; Ward PJ; Chester PC; Latham AN
    J Hum Hypertens; 1988 Mar; 1(4):305-10. PubMed ID: 3065507
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and tolerability of enalapril and sustained-release verapamil in older patients with mild to moderate essential hypertension.
    Weir MR; Cassidy CA; Hall PS; Lancaster A; Schubert C; Urick A; Saunders E; Kong BW; Jenkins P; Lavin PT
    Clin Ther; 1990; 12(2):139-48. PubMed ID: 2354483
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Studies with sustained-release verapamil in essential hypertension.
    Silke B
    Br J Clin Pract Suppl; 1988 Apr; 60():53-7. PubMed ID: 3151272
    [No Abstract]   [Full Text] [Related]  

  • 6. Verapamil versus nifedipine in slow-release preparations for the treatment of mild to moderate hypertension.
    Shamiss A; Meisel S; Nussinovitch N; Rosenthal T
    J Hum Hypertens; 1990 Aug; 4(4):465-8. PubMed ID: 2258895
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A new sustained-release formulation of verapamil in the treatment of hypertension.
    Midtbo KA; Hals O; Lauve O
    J Clin Hypertens; 1986 Sep; 2(3 Suppl):125S-132S. PubMed ID: 3540222
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Efficacy and tolerability of verapamil in mild to moderate hypertension].
    Kahn JC; Pathé M; Maarek-Charbit M; Galey-Arcangioli C
    Ann Cardiol Angeiol (Paris); 1990 Apr; 39(4):247-50. PubMed ID: 2195976
    [No Abstract]   [Full Text] [Related]  

  • 9. Verapamil SR 240 mg as a contribution to compliance in long-term treatment of hypertension.
    Reinfrank J; Eckardt A; Hahn KJ
    Bibl Cardiol; 1987; (42):156-60. PubMed ID: 3307756
    [No Abstract]   [Full Text] [Related]  

  • 10. Verapamil for hypertension.
    Med Lett Drugs Ther; 1987 Apr; 29(737):37-8. PubMed ID: 3561323
    [No Abstract]   [Full Text] [Related]  

  • 11. [Tests for efficacy and tolerance of isoptin SR 240 in treatment of hypertension--BISON].
    Cedro K; Dłuzniewski M; Szpytma M
    Wiad Lek; 1993 Dec; 46(23-24):885-92. PubMed ID: 7900383
    [No Abstract]   [Full Text] [Related]  

  • 12. [Use of isoptin SR-240 in treatment of hypertension].
    Knypl K; Brym E; Wacławek-Maczkowska J
    Wiad Lek; 1993 Dec; 46(23-24):898-901. PubMed ID: 7900385
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dose initiation of calcium antagonists in the treatment of hypertension.
    Müller FB; Erne P; Hotz M; Bolli P; Follath F; Bühler FR
    J Clin Hypertens; 1986 Sep; 2(3 Suppl):118S-124S. PubMed ID: 3794763
    [No Abstract]   [Full Text] [Related]  

  • 14. [Plasma levels and noninvasive hemodynamic profile of slow release verapamil (240 mg). A multicenter study].
    Vulpis V; Seccia TM; Ricci S; Pirrelli A
    Riv Eur Sci Med Farmacol; 1993; 15(5-6):227-35. PubMed ID: 7761676
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety of controlled-onset extended-release verapamil in middle-aged and older patients with hypertension and coronary artery disease.
    White WB; Johnson MF; Anders RJ; Elliott WJ; Black HR
    Am Heart J; 2001 Dec; 142(6):1010-5. PubMed ID: 11717605
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term safety and efficacy comparison of immediate-release and sustained-release oral verapamil in systemic hypertension.
    Frishman WH; Eisen G; Charlap S; Strom JA
    J Clin Hypertens; 1987 Dec; 3(4):605-9. PubMed ID: 3134517
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effectiveness and tolerance of combined verapamil retard and hydrochlorothiazide. Results of a double-blind, randomized study].
    von Manteuffel GE; Rakette S; Woll EM; Reinfrank J; Schiemann J
    Fortschr Med; 1995 Sep; 113(26):374-8. PubMed ID: 7498858
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of short-term oral verapamil on exercise hemodynamics and oxygen delivery in patients with hypertension.
    Cody RJ; Kubo SH; Laragh JH
    J Clin Hypertens; 1986 Sep; 2(3 Suppl):47S-54S. PubMed ID: 3794765
    [No Abstract]   [Full Text] [Related]  

  • 19. [Hypotensive efficacy of verapamil alone and in combination with a diuretic in the treatment of essential hypertension in geriatric patients].
    Latini R; Pierandrei G; Achilli L; Lombi V; D'Amico F
    G Ital Cardiol; 1987 Feb; 17(2):144-8. PubMed ID: 3301500
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Once-daily verapamil in hypertension: intra-arterial recording of blood pressure.
    Brigden GS; Caruana MP; Heber ME; Raftery EB
    Br J Clin Pract Suppl; 1988 Apr; 60():48-52. PubMed ID: 3151271
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.